AzTrials
AzTrials

Social Isolation in Older AdultsNCT07123298

CAPABLE Care + Connect

A study testing CAPABLE Care + Connect - Open Label Pilot and CAPABLE Care + Connect - Pilot in people with Social Isolation in Older Adults and Social Isolation or Loneliness, run by Johns Hopkins University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

In this evaluation scale-up research project, the investigators seek to test an implementation of CAPABLE on the infrastructure of home-based primary care for individuals who may experience social isolation and/or loneliness. Read more about this study

Who is it for?
Ages 50 years and olderHealthy volunteers can take part
What is being tested?
CAPABLE Care + Connect - Open Label Pilot and CAPABLE Care + Connect - Pilot
Could I receive a placebo?
No, everyone receives an active treatment
How many people
450 participants
Where
1 siteUnited States
Study dates
14 Aug 2025to May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Any patient currently in JHOME
  • At risk for or experiencing social isolation as defined by the Lubben Social Network Scale 6 item score less than or equal 12 points or loneliness as defined by the UCLA Loneliness Scale 3 item score of 6 to 9 points
  • Cognitive inclusion criteria Montreal Cognitive Assessment (MOCA) >23 as determined by referring JHOME study team member provider
  • English speaking (measures are standardized in English)
  • Ability to participate in an approximately 45-60 min virtual or in person meeting
  • Eligible for CAPABLE
Show all 13Show fewer
  • 50 years or older
  • Not hospitalized over night more than 4 times in the last 12 months
  • Have some difficulty with any ADL
  • Cognitively intact
  • Live in Baltimore County or Baltimore City
  • Not receiving active cancer treatment
  • Interested in participating in CAPABLE Care partners will be included if the care partners provide > 10 hours of care/week

Who cannot join

  • Terminally ill
  • live in long term care setting
  • receiving active cancer treatment
  • Standard of Care/Comparison group Inclusion Criteria:
  • Any patient currently in JHOME who did not receive the CAPABLE intervention

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Chloe Wynn, MS contact

667-208-7444

cwynn3@jh.edu

United States1 site, 1 recruiting
  • Johns Hopkins School of Nursing

    Baltimore, Maryland, 21205

    Recruiting

Other trials in United States

About this study

Official title: CAPABLE Care + Connect: Pilot Feasibility of Implementing CAPABLE Into Homebased Primary Care

In this evaluation scale-up research project, the investigators seek to test an implementation of CAPABLE on the infrastructure of home-based primary care for individuals who may experience social isolation and/or loneliness. These two home-based care programs may improve each other and provide opportunity to further improve quality of life for people living with disabilities and the caregivers. The purpose of this mixed methods study is to adapt and test CAPABLE, an existing evidence-based program, to a new target population with the scalable infrastructure of home-based primary care.

Read the detailed description

CAPABLE is a home-based, interdisciplinary, goal-directed program that reduces physical disability by working with the person and environment. This program has shown improved performance of activities of daily living (ADL), instrumental activities of daily living (IADL), and depression. Coordinating CAPABLE and Johns Hopkins Home-Based Medicine (JHOME) can help address barriers to health, function, and social connection. Amid limited to no evidence-based strategies to address social isolation and loneliness, this study offers a unique opportunity to address this problem. Because CAPABLE addresses environmental and personal needs to improve the ADL and IADL function of people with disabilities, combining the two programs may better enable people who are homebound to more easily navigate and access the home or beyond. Additionally, this effort will enable the investigators to explore the impact of this combined intervention on social isolation and loneliness.

As in CAPABLE (NA_00031539), the delivery characteristics of CAPABLE Family consist of an assessment-driven, individually tailored package of interventions delivered over the course of 4 months by an occupational therapist (OT) (~6 home visits for ≤ 1hour), a registered nurse (RN) (~4 home visits for ≤ 1hour) and a handy worker (HW).

The purpose of this mixed methods study is to adapt and test CAPABLE, an existing evidence-based program, to a new target population with the scalable infrastructure of home-based primary care. The investigators seek to explore if the CAPABLE program increases social connection in homebound older adults, and if the benefits of CAPABLE services improve social connections among socially isolated/lonely homebound older adults.

Being tested
CAPABLE Care + Connect - Open Label Pilot, CAPABLE Care + Connect - Pilot
Medical subject headings
Social Isolation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CAPABLE Care + Connect - Open Label PilotBehavioural

    As in CAPABLE, the delivery characteristics of CAPABLE Care + Connect consist of an assessment-driven, individually tailored package of interventions delivered over the course of 4 months by an occupational therapist (OT) (~6 home visits for ≤ 1hour), a registered nurse (RN) (~4 home visits for ≤ 1hour) and a handy worker (HW). Adaptations targeting those in JHOME will be made on a per-client basis as part of the open-label pilot. The investigators will further refine and develop the intervention by receiving feedback from the open label pilot participants and CAPABLE clinicians who implemented the pilot to gain those perspectives of the acceptability and feasibility of implementing the CAPABLE Care + Connect intervention. Based on this feedback, the study team will have developed an adapted iteration of the prototype.

  • CAPABLE Care + Connect - PilotBehavioural

    As in CAPABLE, the delivery characteristics of CAPABLE Care + Connect consist of an assessment-driven, individually tailored package of interventions delivered over the course of 4 months by an occupational therapist (OT) (~6 home visits for ≤ 1hour), a registered nurse (RN) (~4 home visits for ≤ 1hour) and a handy worker (HW). Refinements based on the open label pilot results will be included.

Study groups in NCT07123298
Study groupRoleWhat they receive
Open-Label PilotExperimentalThe Open Label Pilot will include testing the CAPABLE Care + Connect intervention on a total of 8. The investigators will recruit and provide CAPABLE to four caregiver-patient dyads (eight participants) and four older adults without caregivers.
Receives: Behavioral: CAPABLE Care + Connect - Open Label Pilot
Pilot- InterventionExperimentalThe investigators will recruit fifteen new partner-patient dyads and fifteen participants without caregivers to receive CAPABLE. That is a total of 45 participants that will receive the CAPABLE intervention
Receives: Behavioral: CAPABLE Care + Connect - Pilot
Standard of Care GroupNo interventionThe standard of care/comparison group will apply for JHOME patients. There are currently around 400-450 patients in JHOME, therefore, our total sample size including both intervention and standard of care group will be up to 450 people. It is important to note that the standard of care group is for individuals who did not complete the intervention and is used to evaluate the effectiveness of the intervention itself. Those eligible for the intervention will be included in the study, whereas those ineligible based on intervention screen will be asked about record review. If those ineligible decline record review, those ineligible will be excluded from entire study.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Function as assessed by the Katz Index of Independence in Activities of Daily Living Scale

    6 questions, each 1 point for a total score range of 1- 6. A score closer to 6 indicates high patient independence, better outcome.

    Measured: Baseline, 16 weeks

  2. Change in Function as assessed by Lawton & Brody's assessment of Instrumental Activities of Daily Living Scale (IADL)

    Participants rate their ability to perform daily tasks on a 5-point scale (1 = no difficulty, 2 = a little difficulty, 3 = moderate difficulty, 4 = a lot of difficulty, 5 = unable to do). Score range 8 to 40, higher scores represent greater difficulty performing ADLs, worse outcome.

    Measured: Baseline, 16 weeks

  3. Change in Pain as assessed by the Brief Pain Inventory Scale (Short Form)

    The Brief Pain Inventory - Short Form is a 9 item self-administered questionnaire used to evaluate the severity of a patient's pain and the impact of this pain on the patient's daily functioning. For the 10 point scale, 0 indicated no pain and 10 indicates the worst imaginable pain. Score range 0-90, higher score worse outcome.

    Measured: Baseline, 16 weeks

  4. Change in Function as assessed by the American Community Survey Disability Measure

    This measure is used to identify whether a person is considered to have a disability based on responses to six standardized questions. A person is considered to have a disability if the person answers "Yes" to at least one of the six questions. There is no composite score.

    Measured: Baseline, 16 weeks

  5. Change in Depression as assessed by the Patient Health Questionnaire Depression Scale (PHQ-8)

    The PHQ-8 contains 8 questions, with a 0-3 scale. A score of 10 or greater is considered major depression, 20 or more is severe major depression. Score range 0-24, higher score worse outcome.

    Measured: Baseline, 16 weeks

  6. Change in Social Connection as assessed by the Lubben Social Network Scale

    The Lubben Social Network Scale - 12 item version (LSNS-12) includes 12 questions, each scored from 0 to 5 based on the number of social contacts, with total scores ranging from 0 to 60, where lower scores indicate greater social isolation, worse outcome.

    Measured: Baseline, 16 weeks

  7. Change in Social Connection as assessed by the University of California Los Angeles (UCLA) Loneliness Scale

    The UCLA Loneliness Scale (20-item version) includes 20 questions, each rated on a 1 to 4 scale, with total scores ranging from 20 to 80, where higher scores indicate greater perceived loneliness, worse outcome.

    Measured: Baseline, 16 weeks

  8. Change in Social Connection as assessed by qualitative questions

    2 open ended questions about social network. Qualitatively look at answers from descriptive perspective

    Measured: Baseline, 16 weeks

  9. Change in Caregiver Burden as assessed by Zarit Burden Inventory

    The Zarit Burden Interview - 12 item version includes 12 questions, each scored from 0 (never) to 4 (nearly always), for a total score range of 0 to 48, with higher scores indicating greater caregiver burden, worse outcome.

    Measured: Baseline, 16 weeks

  10. Change in Perceived Change in Function Scale

    14 questions related to perceived improvement in function. Scale of -2 (gotten much worse) to 2 (improved a lot). The higher the overall score, the greater the improvement, better outcome.

    Measured: 16 weeks

  11. Change in Caregiver Burden as assessed by the Oberest Caregiver Burden Scale

    The Oberst Caregiver Burden Scale includes 15 items rated on a 5-point scale assessing the time and difficulty of caregiving tasks, with total scores ranging from 15 to 75 per subscale and higher scores indicating greater burden.

    Measured: Baseline, 16 weeks

  12. Change in Caregiver Outcomes as assessed by the Bakas Caregiving Outcomes Scale

    The Bakas Caregiving Outcomes Scale includes 15 items, each rated on a 7-point scale from -3 (changed for the worst) to +3 (changed for the best), with total scores reflecting the caregiver's perceived changes in life due to caregiving. Higher score better.

    Measured: Baseline, 16 weeks

  13. Change in Pain as assessed by the Brief Pain Inventory (Short Form)

    The Brief Pain Inventory - Short Form is a 9 item self-administered questionnaire used to evaluate the severity of a patient's pain and the impact of this pain on the patient's daily functioning on a 10 point scale. 0 = no pain and 10 indicates the worst imaginable pain. Higher score worse outcome.

    Measured: Baseline, 16 weeks

  14. Change in Pain as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference Short Form

    The PROMIS Pain Interference Short Form includes 6 questions, each rated on a 5-point scale, with raw scores summed and converted to a T-score, where higher scores indicate greater interference from pain in daily activities.

    Measured: Baseline, 16 weeks

Secondary outcomes (4)
  1. JHOME Health System Effects- Number Urgent Visits

    Frequency (number) of urgent visits

    Measured: 6 months prior to program, 16 weeks

  2. JHOME Health System Effects- Number Emergency Room Visits

    Frequency (number) of emergency room visits

    Measured: 6 months prior to program, 16 weeks

  3. JHOME Health System Effects - Nursing Home Placement

    Yes/No to being placed in nursing home

    Measured: 16 weeks

  4. JHOME Health System Effects- Number of Medications

    Number of medications prescribed

    Measured: 6 months prior to program, 16 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Aug 2025
  2. Study start14 Aug 2025
  3. Primary completionMay 2027 (estimated)
  4. Study completionMay 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
The investigators will have a standard of care group and an intervention group. The intervention group will receive the CAPABLE intervention, and the standard of care group is designed to look at long term outcomes of JHOME patients who did not enroll in CAPABLE compared to those who did.
Masking
None (open label)
Enrolment
450 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07123298
Sponsor's protocol ID
IRB00471865
Status last verified
Jun 2026
First submitted
7 Aug 2025
Last updated
2 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing CAPABLE Care + Connect - Open Label Pilot and CAPABLE Care + Connect - Pilot in people with Social Isolation in Older Adults and Social Isolation or Loneliness, run by Johns Hopkins University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 13 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Chloe Wynn, MS (667-208-7444, cwynn3@jh.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Function as assessed by the Katz Index of Independence in Activities of Daily Living Scale (time frame: Baseline, 16 weeks). The study lists 14 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in